ABSTRACT OBJECTIVES This study sought to examine the relationships between in-hospital and post-discharge body weight changes and outcomes among patients hospitalized for acute heart failure (AHF).
BACKGROUND Body weight changes during and after hospitalization for AHF and the relationships with outcomes have not been well characterized.
METHODS A post hoc analysis was performed of the ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and
Decompensated Heart Failure) trial, which enrolled patients admitted for AHF regardless of ejection fraction. In-hospital body weight change was defined as the difference between baseline and discharge/day 10, whereas post-discharge body weight change was defined as the difference between discharge/day 10 and day 30. Spearman rank correlations of weight change, urine output (UOP), and dyspnea relief as assessed by a 7-point Likert scale are described. Logistic and Cox proportional hazards regression was used to evaluate the relationship between weight change and outcomes.
RESULTS Study participants with complete body weight data (n ¼ 4,172) had a mean age of 65 AE 14 years, and 66% were male.
Ischemic heart disease was reported in 60% of patients and the average ejection fraction was 30 AE 13%. The median change in body weight was À1.0 kg (interquartile range: À2.1 to 0.0 kg) at 24 h and À2.3 kg (interquartile range: À5.0 to À0.7 kg) by discharge/day 10. At hour 24, there was a weak correlation between change in body weight and UOP (r ¼ À0.381), and minimal correlation between body weight change and dyspnea relief (r ¼ À0.096). After risk adjustment, increasing body weight during hospitalization was associated with a 16% increase per kg in the likelihood of 30-day mortality or HF readmission for patients showing weight loss #1 kg or weight gain during hospitalization (odds ratio per kg increase 1.16, 95% confidence interval [CI]: 1.09 to 1.27; p < 0.001). Among the subset of patients experiencing >1-kg increase in body weight post-discharge, increasing body weight was associated with higher risk of 180-day mortality (hazard ratio per kg increase 1.16; 95% CI: 1.09 to 1.23; p < 0.001).
CONCLUSIONS A substantial number of patients experienced minimal weight loss or frank weight gain in the context of an AHF trial, and increasing body weight in this subset of patients was independently associated with a worse post- Despite the fundamental role congestion plays in AHF, there is little consensus among clinicians with respect to assessing and grading congestion during hospitalization. Moreover, limited data exist regarding the association between congestion, symptoms, changes in weight, and outcomes in patients following a hospitalization for AHF.
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change was defined as the absolute difference between baseline and discharge or day 10, whichever occurred first, whereas post-discharge body weight change was defined as the absolute difference between discharge/ day 10 and day 30. Study participants with a body weight change less than the 1st percentile or greater than the 99th percentile were excluded. In-hospital body weight change was categorized as significant loss (i.e., change <À5 kg), moderate loss (i.e., À5 kg # change <À1 kg), no loss (i.e., À1 kg # change <1 kg), and gain (i.e., change $1 kg). Dyspnea relief was measured 24 h after enrollment using a self-reported 7-point Values are median (interquartile range) or n (%). *Significant loss: <À5 kg; moderate loss: À5 kg to À1 kg; no loss: À1 kg to 1 kg; gain: $1 kg.
ACEI/ARB ¼ angiotensin converting-enzyme inhibitor/angiotensin receptor blocker; BMI ¼ body mass index; BNP ¼ B-type natriuretic peptide; bpm ¼ beats per minute; BUN ¼ blood urea nitrogen; DBP ¼ diastolic blood pressure; GFR ¼ glomerular filtration rate; ICD/CRT ¼ implantable cardioverter defibrillator/cardiac resynchronization therapy; JVD ¼ jugular venous distension; LOS ¼ length of stay; MRA ¼ mineralocorticoid receptor antagonist; NT-proBNP ¼ N-terminal pro-B-type natriuretic peptide; NYHA ¼ New York Heart Association; QE ¼ qualifying episode; SBP ¼ systolic blood pressure.
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RESULTS STUDY POPULATION.
A total of 4,172 patients had body weight measured at baseline and discharge/ day 10. Study participants had a mean age of 65 AE 14 years, 65% were male, and 47% self-identified as nonwhite ( Table 1) . Ischemic heart disease was reported in 60% of patients, and the average ejection fraction was 30 AE 13%. The prevalence of cardiac and noncardiac comorbidities was high, and patients were well treated with guideline-directed medical therapies.
CLINICAL COURSE OF BODY WEIGHT CHANGE. The median change in body weight was À1.0 kg (À2.1 to 0.0) at hour 24 and À2.3 kg (À5.0 to À0.7) at discharge/day 10 ( Figure 1) . Overall, 67% of patients (n ¼ 2,776) showed significant (i.e., change <À5 kg) or moderate weight loss (i.e., À5 kg # change <À1 kg) during hospitalization, whereas 26% (n ¼ 1,068) showed no loss (i.e., À1 kg # change <1 kg) and 8% (n ¼ 328) experienced weight gain (i.e., change $1 kg). Between discharge/day 10 and day 30, study participants re- 
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The distribution of (A) absolute and (B) relative in-hospital body weight change at hour 24, discharge/day 10, and day 30.
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The association between in-hospital body weight change and 180-day mortality did not reach the threshold for statistical significance (p ¼ 0.086) in this subset of patients after risk adjustment ( Table 4) . 
DISCUSSION
This study found that more than 30% of patients admitted for a primary diagnosis of AHF Change in body weight, kg Dyspnea relief À0.09600 <0.0001
Change in body weight, kg Urine output À0.38100 <0.0001
Dyspnea relief Urine output 0.11100 <0.0001
*Spearman rank correlation coefficient.
FIGURE 2 Body Weight Change and Dyspnea
The correlation between in-hospital body weight change and dyspnea relief at 24 h.
Body Weight Change in Acute Heart Failure The correlation between in-hospital body weight change and urine output (UOP) at 24 h.
FIGURE 4 UOP and Dyspnea
The correlation between urine output (UOP) and dyspnea relief at 24 h.
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FIGURE 5 sCr and Change in Body Weight
Serum creatinine (sCr) over time by in-hospital body weight change. CI ¼ confidence interval.
FIGURE 6 BUN and Change in Body Weight
Blood urea nitrogen (BUN) over time by in-hospital body weight change. CI ¼ confidence interval.
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